 |
|
Is the Self-counting of Moles a Valid Method of Assessing Melanoma Risk?
Arch Dermatol. 2000;136:1550-1551.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination
Buettner PG, Garbe C
Am J Epidemiol. 2000;151:72-77
The objective was to determine whether people can identify themselves as being at risk for melanoma through the self-counting of moles. In this case-control study, the patient population consisted of 513 patients with melanoma diagnosed in 1991 who were recruited from 9 cooperating university dermatology departments in Germany, Austria, and Switzerland. The controls were 498 patients without melanoma from the participating dermatology clinics. Subjects were provided with information about the self-assessment of benign melanocytic nevi using German colloquial terms for the description of common and atypical nevi. Examinations by dermatologists took place after the self-assessments and were used as the criterion standard. Patients and dermatologists were specifically asked to categorize the total number of melanocytic nevi on the whole body (0, 1-9, 10-19, 20-39, 40-59, 60-100, or >100). They . . . [Full Text of this Article] Editor's Comment
RELATED ARTICLE
Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer: A Critical Review of the Literature and Meta-analysis
Isabelle Marcil and Robert S. Stern
Arch Dermatol. 2000;136(12):1524-1530.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Multiple Interpretations of Cancer Risks From Body Mole Counts in Preventive Care
Fusaro
Arch Dermatol 2001;137:823-823.
FULL TEXT
|
